NCT03086369 2022-06-28A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic CancerEli Lilly and CompanyPhase 1/2 Completed184 enrolled 22 charts
NCT01316263 2017-03-09A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal TumorsEli Lilly and CompanyPhase 2 Terminated21 enrolled 24 charts